European Archives - Page 362 of 1054 - European Medical Journal

Eli Lilly improves cold chain capacity

Eli Lilly has pledged over $1m to improve cold chain capacity for insulin in low- to middle-income countries.

Pharma in Poland

Travel to Poland to discover the factors driving its pharmerging status and access to medicine challenges.

A Voice in the Wilderness: Treating Headache and Migraine

The correct classification and differentiation of headaches and migraines are key in their management.

Epidemiological Features of SARS-CoV-2 in Northern Greece

The COVID-19 pandemic has been a huge challenge for the Greek National Health System. Real-time reverse transcription PCR (rtRT-PCR) remains the reference method for early diagnosis, contact tracing, and containment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Reflections and predictions for 2023

Explore the key trends and themes industry experts predict will be in store for pharma over the next 12 months.

Mental health matters in pharma's approach to care

Treatments for cancer are continuously advancing, but pharma must also focus on supporting patients’ mental health.

Attracting diverse talent into STEM

This infographic explores how the pharmaceutical industry is attracting and supporting the future STEM workforce with DE&I initiatives.

The Efficacy and Safety of SARS-CoV-2 Vaccinations in People with Multiple Sclerosis

While people with multiple sclerosis (MS) are not more likely to contract COVID-19, the incidences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19-related complications may be higher for people with MS who have comorbidities or who are taking certain disease modifying therapies (DMT).

EMJ Neurology 11 [Supplement 1] 2023

While people with multiple sclerosis (MS) are not more likely to contract COVID-19, the incidences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19-related complications may be higher for people with MS who have comorbidities or who are taking certain disease modifying therapies (DMT).

Newer Oral Levothyroxine Formulations: Is It Time to Switch Over?

Primary hypothyroidism is a frequent presentation in primary care, and is treated with levothyroxine sodium tablets once daily in the morning in the fasting state.